Evidence map›Paper›PMID 35426356›Full record

ArticleInternational journal of circumpolar health2022

Testing of a mobile heating facility to sanitize N-95 respirators against an enveloped respiratory virus.

Michael Brubaker, William Fraser, Keith Cook, Ralf Dagdag, Abigail Nelson, John Warren, Timothy Thomas, Elle Lovejoy, Thomas Kosten, Brandon Maniaci and 2 more

Abstract read
In one paragraph

Article in International journal of circumpolar health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Michael BrubakerDepartment of Community Environment and Health, Community Environment & Health, Alaska Native Tribal Health Consortium (ANTHC), Anchorage, AK USA.
William FraserEngineering ANTHC Anchorage, AK, USA.
Keith CookStatewide Health Facilities, ANTHC, Anchorage, AK, USA.
Ralf DagdagDepartment of Biological Sciences, University of Alaska Anchorage (UAA), Anchorage, AK, USA.
Abigail NelsonCommunity Environment and Health, ANTHC, Anchorage, AK, USA.
John WarrenDirector, Department of Standards and Innovation, Standards and Innovation ANTHC, Anchorage, AK, USA.
Timothy ThomasClinical and Research Services, ANTHC, Anchorage, AK, USA.ORCID 0000-0001-9958-8411
Elle LovejoyDentist, Department of Dental Health Services, Tanana Chiefs Conference, Fairbanks, AK, USA.
Thomas KostenDepartment of Biological Sciences, UAA, Anchorage, AK, USA.
Brandon ManiaciDepartment of Biological Sciences, UAA, Anchorage, AK, USA.
Eric BortzDepartment of Biological Sciences, UAA, Anchorage, AK, USA.
Jacob GrayDirector, Internal Medicine, Alaska Native Medical Center, Anchorage, AK, USA.

Funding

The Administrative CoreP20GM103395 · NIGMS · UNIVERSITY OF ALASKA FAIRBANKS · PI BRIAN M BARNES · 2012 to 2026
$66.1M
NIAID NIH HHS HHSN272201400008CNIGMS NIH HHS P20 GM103395
6 · The paper itself

Abstract

In the spring of 2020, the Alaska Native Tribal Health Consortium (ANTHC) designed and built a sanitizing treatment system to address shortages of filtering facepiece respirators (FFRs). The design criteria included sanitizing large numbers of FFRs, repeatedly achieving FFR fit test requirements, and deactivating enveloped respiratory viruses, such as SARS-CoV-2. The outcome was the Mobile Sanitizing Trailer (MST), a 20 by 8-foot modified trailer designed to process up to 1,000 FFRs during a standard heat cycle. This paper reports on the MST's ability to: (1) sustain a target temperature, (2) produce tolerable conditions for FFRs as measured by fit factor and (3) successfully deactivate an infectious model virus. We found that the MST reliably and uniformly produced 75 degrees Celsius in the treatment chamber for the prescribed periods. Quantitative analysis showed that the FFRs achieved acceptable post-treatment fit factor even after 18, 60-minute heat cycles. Finally, the treated FFR materials had at least a log 3.0 reduction in viral RNA and no viable virus after 30, 60 or 90 minutes of heat treatment. As a sanitizing treatment during supply shortages, we found the MST a viable option for deactivation of virus and extending the usable life of FFRs.

Indexed as

COVID-19VirusesHeatingHumansSARS-CoV-2Ventilators, Mechanicalfiltering facepiece respiratorreuseSARS-CoV-2temperaturevirus inactivation

Identifiers

PMID35426356
PMCPMC9037215

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.